Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
02:21pm, Tuesday, 18'th Oct 2022 Benzinga
Upgrades
According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur
4 Toxic Stocks That May Stress You Out Amid Market Turmoil
12:48pm, Thursday, 13'th Oct 2022 Zacks Investment Research
Just like identifying promising stocks, detecting toxic stocks and dumping them at the right time are crucial to safeguarding one's portfolio from big losses.
4 Toxic Stocks That May Stress You Out Amid Market Turmoil
10:32am, Thursday, 13'th Oct 2022
Just like identifying promising stocks, detecting toxic stocks and dumping them at the right time are crucial to safeguarding one's portfolio from big losses.
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
02:02pm, Wednesday, 12'th Oct 2022 Benzinga
Upgrades
For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte
Got $1,000? These 3 Stocks Could Double Your Money in 5 Years.
02:00pm, Wednesday, 12'th Oct 2022 The Motley Fool
All three stocks are worth keeping a lot longer than half a decade.
5 Analysts Have This to Say About Tandem Diabetes Care
01:24pm, Wednesday, 12'th Oct 2022 Benzinga
Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
0
1
0
Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022
04:05pm, Tuesday, 04'th Oct 2022
SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the f
Zacks.com featured highlights InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group
09:00am, Friday, 23'rd Sep 2022 Zacks Investment Research
InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group have been highlighted in this Screen of The Week article.
4 Toxic Stocks That May Risk Your Peace and Prosperity
01:09pm, Thursday, 22'nd Sep 2022 Zacks Investment Research
Stocks like INVV, SPR, TNDM and HCI could prove hazardous for your portfolio. So, it's best to dump these toxic stocks, especially amid the prevailing market mayhem.
4 Toxic Stocks That May Risk Your Peace and Prosperity
10:32am, Thursday, 22'nd Sep 2022
Stocks like INVV, SPR, TNDM and HCI could prove hazardous for your portfolio. So, it's best to dump these toxic stocks, especially amid the prevailing market mayhem.
Chemours, Alcoa And Other Big Losers From Wednesday
09:59am, Thursday, 22'nd Sep 2022 Benzinga
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.
iRhythm Technologies, Inc. (NASDAQ:
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
08:04am, Thursday, 22'nd Sep 2022 Benzinga
Gainers
Stabilis Solutions, Inc. (NASDAQ: SLNG) shares climbed 71.3% to close at $8.84 after the company announced it has received authorization from the U.S. Department of Energy to export domestic
Tandem Diabetes (TNDM) Faces Expense Woes, Macro Issues
04:08pm, Friday, 16'th Sep 2022 Zacks Investment Research
Factoring in the pandemic and competitive pressure as well as evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) slashes full-year guidance.
Tandem Diabetes (TNDM) Faces Expense Woes, Macro Issues
01:33pm, Friday, 16'th Sep 2022
Factoring in the pandemic and competitive pressure as well as evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) slashes full-year guidance.
These 2 Stocks Have Plenty of Room to Run
02:45pm, Friday, 09'th Sep 2022 The Motley Fool
The market has punished both companies this year, but their long-term prospects remain intact.
